Trinity biotech announces the appointment of aris kekedjian as chairman and ceo

Dublin, ireland, oct. 03, 2022 (globe newswire) -- trinity biotech plc (nasdaq: trib), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the appointment of mr. aris kekedjian as ceo with effect from october 3, 2022. he succeeds mr. ronan o'caoimh, co-founder of trinity biotech, who will remain on the trinity biotech plc board of directors to advise the company going forward. in addition, mr. kekedjian has also assumed the role of chairman of the board of directors of trinity biotech plc.
TRIB Ratings Summary
TRIB Quant Ranking